ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
ARVINAS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$7.26+0.29 (+4.16%)
Close on Oct 19, 2026
- Market cap
- $476.98M
- P/E (TTM)
- 45.4
- Dividend yield
- –
Dividends
Arvinas has not reported a dividend
No dividend per share appears in Arvinas's annual filings since fiscal 2016.